Pathological diagnosis of melanocytic tumours: clues and pitfalls # Richard A. Scolyer 1,2,3* and Stanley W. McCarthy 1,2,3

Size: px
Start display at page:

Download "Pathological diagnosis of melanocytic tumours: clues and pitfalls # Richard A. Scolyer 1,2,3* and Stanley W. McCarthy 1,2,3"

Transcription

1 Pathological diagnosis of melanocytic tumours: clues and pitfalls # Richard A. Scolyer 1,2,3* and Stanley W. McCarthy 1,2,3 1 Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. 2 Melanoma Institute Australia, Sydney, Australia. 3 Discipline of Pathology, Sydney Medical School, The University of Sydney, NSW, Australia. *Supported by a Cancer Institute New South Wales Clinical Research Fellowship In Australia and many other countries, melanoma is a major public health problem particularly in those individuals of Celtic ancestry. Other races are not immune, especially when acral and mucosal sites are taken into account. Accurate diagnosis requires the balancing of clinical data (including patient age and sex, family history, the anatomic site of the lesion, the history of the lesion and other factors such as a history of trauma, sunburn or pregnancy), histological features (including architecture, cytology and the host response), awareness of pitfalls and judgment. Several types of naevi are prone to be misdiagnosed as melanoma such as regenerating naevi, combined naevi, acral naevi, deep penetrating naevi and Spitz naevi. Melanomas often underdiagnosed include naevoid melanomas, desmoplastic melanomas, Spitzoid melanomas and regressed melanomas. The type of biopsy and suboptimal processing may also significantly influence the diagnosis. PATHOLOGICAL DIAGNOSIS Accurate pathological diagnosis of melanocytic tumours requires a suitable biopsy, assessment of many histological criteria, an awareness of potential pitfalls, relevant experience and, in difficult cases, judicious consultation 1-5. Correlation of a range of basic morphological and clinical features is necessary because many of the individual features are shared by both naevi and melanomas. In the future, molecular and genetic studies may be useful adjuncts for an accurate diagnosis, particularly for difficult lesion for which it is not possible to be certain from its histological features whether the lesion is benign or malignant Morphological features of importance (Table 1): Architectural: Good symmetry is often associated with benign behaviour. Poor symmetry and irregular margins are more often found in dysplastic, traumatised and malignant melanocytic tumours. Ulceration, vascular invasion, neurotropism and satellites are also more frequent in melanomas but can also occasionally occur in naevi. Minor perineural invasion may be found in all types of benign naevi so is not very helpful when diagnosing melanocytic tumours. Pagetoid epidermal invasion is very common and not usually significant in acral lesions, regenerating naevi ( pseudomelanoma ) or irritated naevi (trauma, sunburn etc.) 5 9.

2 Cytological: Cytological features may be deceptive especially in naevoid melanomas with small cells and uniform cytology, deep penetrating naevi with nuclear pleomorphism and regenerating naevi with epithelioid cells. Nucleoli when irregular or frequent (average > 2 nucleus) usually indicate dysplasia or malignancy. Mitoses when abnormal, frequent (>2/mm²) or deep in the lesion are always of concern and should be regarded as being of at least uncertain malignant potential especially when occurring in post pubertal patients. Host response: This is usually cellular and/or stromal. Cellular: Regressing tumours, benign or malignant, are usually infiltrated, at least initially, by lymphocytes. Scattered foci of lymphocytes are a common feature in desmoplastic melanoma. Benign naevi and some aggressive epithelioid melanomas lack a cellular response. Stromal: Periretal lamellar collagen is common in dysplastic naevi and may be very thick in severe forms. Fibrosis is variable in desmoplastic melanoma. Pure forms (100% desmoplastic) appear to have a better prognosis and less frequent nodal metastases 10. Table 1: Morphological Features of Melanoma Architectural Asymmetry Irregular margins Ulceration Vascular invasion Microsatellites Pagetoid epidermal invasion Cytological Nucleoli (especially if irregular and multiple) Deep or frequent mitoses Poor maturation Host response Lymphocytic infiltrate Stromal fibrosis (especially in desmoplastic melanoma) Regression Clinical features of importance: Age: Melanomas are uncommon in children just as Spitz naevi are rare in middle and older age groups. Vulval melanoma is rare below the age of 40 years. Sex: Melanomas with Spitzoid features appear to be more common in young males but the reverse is probably true after Females have a better prognosis than male melanoma patients. Family history: Melanomas are common in some families and first degree relatives.

3 Site: Sun-exposed areas are more likely to develop naevi and melanomas in Caucasian patients. Desmoplastic melanomas most commonly involve the head and neck region and are frequently associated with lentigo maligna 12. They may be subtle clinically and histologically and hence may not be diagnosed until they are at an advanced clinical stage. 9 History of lesion: A lesion of long duration which has changed in size or color, become itchy, or bled easily should always be investigated. Any trauma, previous biopsy, sunburn or topical agent may induce regenerative features that simulate malignancy. Pregnancy: May induce frequent mitoses in otherwise banal naevi. THE BIOPSY An excisional biopsy is preferred wherever possible Lesser specimens (punch, shave, curettings) may be distorted and may not permit adequate assessment of the vital parameters needed by the clinician for definitive treatment e.g. Breslow thickness, mitotic rate 13. Smaller specimens may also not be representative of the lesion and usually lack the edges and bases of the lesions needed to assist diagnostic interpretation 3 4. In the subsequent excision specimen it may be impossible to allocate atypical features cellular pleomorphism, mitoses and epidermal invasion to either malignancy or regeneration. A recent study highlighted that histopathological misdiagnosis is more common for melanomas that have been assessed with punch and shave biopsy than with excision biopsy 34. Adverse outcomes due to misdiagnosis were more commonly associated with punch biopsy than with shave and excision biopsy (odds ratio 16.6, p<0.001). The use of punch and shave biopsy also leads to increased microstaging inaccuracy. It is often difficult to separate traumatic fibrosis from regression fibrosis. The latter is more often associated with epidermal atrophy whereas post-traumatic fibrosis in compound naevi often has some overlying variable epidermal thickening. NAEVI PRONE TO MISDIAGNOSIS (Table 2) Table 2: Naevi Prone to Misdiagnosis Regenerating nevus Blue naevi Irritated naevus - Dendritic Post-excisional junctional hyperplasia - Cellular Cellular/hyperplastic nodule - Deep penetrating in congenital naevus - Epithelioid Combined naevus Acral naevi Ancient naevus Balloon and Clear cell naevi Spitz naevus Neurotized naevus Dysplastic naevus Desmoplastic naevus Naevus in pregnancy Halo naevus Genital naevus

4 Regenerating Naevi. Naevi often regenerate after incomplete removal (punch, shave, curette, incision, other trauma). Some naevi, especially compound melanocytic naevi of small congenital type and dysplastic compound naevi, display features often associated with melanoma and are sometimes termed pseudomelanoma. These features include Pagetoid spread of melanocytes, cytological atypia, dermal mitoses and HMB45 positivity. 14 Post-excisional junctional melanocytic hyperplasia at the edge of an excision scar may show some atypia and a tendency to epidermal invasion suggestive of in situ malignancy. Irritated melanocytic naevi may show epidermal invasion but the offending melanocytes tend to have small nuclei. Causes of irritation may be physical e.g. rubbing or scratching, topical agents or strong sunburn. Dysplastic naevi have variable lentiginous hyperplasia, periretal lamellar collagen, architectural disorder and cytological atypia. The cytological atypia may be mild, moderate or severe. Severe atypia or moderate atypia associated with irritative or Spitzoid changes may readily be mistaken for malignancy. The vast majority of dysplastic naevi (the commonest naevi in Caucasians) with mild to moderate cytological atypia are stable or grow very slowly and rarely progress to malignancy. Dysplastic naevi are regarded as intermediate lesions of tumour progression between naevi and melanoma. They show S-phase ploidy and intermediate levels of genetic unstability. Cellular/hyperplastic nodules in congenital naevi may have mitoses but they are not abnormal. The nodules usually have pushing margins and merge with the adjacent banal component of the naevus. Naevi in pregnancy. Dermal and compound naevi of small congenital type in pregnancy may show increased numbers of normal-looking mitoses in the otherwise banal dermal nevomelanocytes and appear to be without clinical significance. Combined naevi are often mistaken clinically and histologically for melanoma because of their biclonal (occasionally triclonal) nature and variability or change in color or shape Frequent problems are combinations of common naevus (common acquired, congenital or dysplastic) associated with pigmented blue naevus (common blue, cellular blue or deep penetrating) or Spitz naevus (conventional, regressing or desmoplastic) 16. The blue naevus or Spitz naevus component may dominate the lesion and show an occasional mitosis. So-called ancient naevi may represent a combined naevus with a regressing or degenerating Spitzoid component. Blue naevi variants cause special problems. Dendritic blue naevi and sclerosing cellular blue naevi may have an infiltrative pattern similar to desmoplastic melanomas but the latter often have some junctional change, are almost invariably non-pigmented and are negative with HMB45. 17

5 Deep penetrating naevi frequently show moderate nuclear pleomorphism, abut nerves and have an occasional dermal mitosis. Rare cases, either large or with scattered mitoses, may involve a regional or sentinel lymph node. Whether this is a benign metastasis or an indication of future malignant progression is controversial. 17 Epithelioid blue naevi (as in Carney s syndrome) and other so-called pigmented epithelioid melanocytomas are also low grade melanocytic tumours that apparently frequently involve regional lymph nodes yet paradoxically appear to have a favourable prognosis 18 and should probably be regarded as being of uncertain malignant potential especially those in children and young adults and when associated with pseudoepitheliomatous hyperplasia. Balloon and clear cell naevi may be confused with their malignant counterparts. The naevi usually have bland nuclei and lack mitoses. Neurotised and desmoplastic common naevi can be confused with desmoplastic melanoma especially of pure type. The naevi, however, lack atypical junctional changes, dermal mitoses and scattered clusters of lymphocytes. Halo or regressing naevi may present with alarming color change, with a darkening centre and pale periphery, especially in children. Most of these atypical compound naevi have a dermal component of smaller darker nevomelanocytes disrupted by lymphocytes, a feature suggestive of early regression. An occasional dermal mitosis does not indicate malignancy. Though most frequent in children, they also occur in middle and old age groups. Acral naevi and genital naevi resemble dysplastic naevi elsewhere in the skin. Focal Pagetoid epidermal invasion, especially in the acral naevi is alone not an indication of malignancy. See also Tables 3 and 4. Table 3: Naevi of Acral Skin: Histopathological Features Which Can Cause Concern Suprabasilar melanocytes ( Pagetoid spread ) (30-79%) Atypical size, shape, location of junctional nests A subset (acral lentiginous naevi) show - Predominantly lentiginous growth - Poor circumscription - Asymmetry Small biopsies Table 4: Acral Naevi v Acral Melanoma: Features favouring melanoma Severe cytological atypia Lymphocytes abutting junctional zone Marked architectural disorder Increased density of melanocytes Excessive Pagetoid spread

6 Poor maturation Expansile growth Dermal mitoses and lymphocytes Spitz naevus and Spitzoid tumours are a common problem and share many of the histological features of melanoma (Table 5) Those with atypical features cause most concern and many are of uncertain biological behavior (Table 6). 20 Table 5: Features of Spitz Naevi Diameter usually < 6mm Telangiectatic vessels Symmetrical Nested & single cell Diffuse epidermal hyperplasia Pagetoid spread Hypergranulosis Maturation and often merging Terminal nests with dermal collagen Uniformity of cells Spindle/epithelioid cells and nests across lesion Mitotic figures <=2/mm² Kamino bodies Absent deep or abnormal mitoses Subepidermal clefts Table 6: Atypical Features for Spitz Naevus Diameter >10mm Peripheral Pagetoid Asymmetry epidermal invasion Ulceration Sparse Kamino bodies (children) Lack of maturation Marked cytological atypia Deep extension Irregular or multiple nucleoli Expansile dermal nests Dermal mitoses >2/mm² Epidermal thinning Deep mitoses Long thin rete ridges Abnormal mitoses An Approach to Atypical Cases. Complete excision is probably mandatory Avoid overdiagnosis to avoid excessive treatment and possible medico-legal action. Give a preferred diagnosis acknowledging the degree of uncertainty. Seek further opinions. The safest course may be to manage the lesion as a melanoma. 21 However, wide local excision may not be appropriate if there is likely to be unacceptable cosmetic disfigurement and any co-morbidity When there is uncertainty about whether a melanocytic tumour is benign or malignant the pathologist should document in their report the thickness of the tumour (and other important features of the tumour such as its mitotic rate and ulcerative state). This information may be utilised by the clinician to manage the patient as for a melanoma of equivalent thickness (and other prognostic parameters) if this is deemed appropriate. MELANOMAS PRONE TO CAUSE DIAGNOSTIC PROBLEMS (Table 7)

7 Table 7: Melanomas Prone to Cause Diagnostic Problems Naevoid melanoma Spitzoid melanoma Desmoplastic melanoma Regressed melanoma Naevoid melanomas mimic a benign naevus. Small and intermediate cell types are sometimes called minimal deviation melanoma (or Lawyer s melanoma because they may not be diagnosed until after they have metastasized and medicolegal action may follow). 14 Large and spindle cell types are called Spitzoid or Spitz naevus-like melanoma. A probable indolent variant resembling a dermal naevus develops on the lower limb of elderly females. Recognition of naevoid melanomas of smaller cell types requires a high index of suspicion and recognition of subtle architectural and cytological features. Architectural features are basic symmetry, good circumscription in a nodular or verrucous pattern lacking any significant radial growth phase or epidermal invasion. Long thin rete ridges, expansile or sheet-like growth and pseudomaturation are common. Subtle cytological atypia is present throughout though mitoses may be sparse and only superficial. HMB45 and Ki67 staining may be helpful in some cases. Desmoplastic melanoma. Desmoplastic melanomas may be difficult to detect clinically as they are usually nonpigmented and may resemble a scar, a dermatofibroma, a basal cell carcinoma or a poorly healing pyogenic granuloma. 9 Histologically they may be confused with immature scars (which may also have S-100 positive spindle cells and foci of lymphocytes), desmoplastic naevi (usually symmetrical lacking atypia, mitoses and lymphocytic foci); desmoplastic Spitz naevi (plump cells and associated epidermal thickening); sclerosing cellular blue naevus (usually HMB45 positive and have foci of melanin pigment); dermatofibroma (tapering storiform margins, epidermal thickening, absent lymphocytes) and with some soft tissue spindle cell sarcomas. Desmoplastic melanomas also often show an associated atypical junctional component (lentigo maligna / Hutchinson s melanotic freckle) and neurotropism. Most are HMB45 and Melan A (MART-1) negative. Pure forms (spindle cells only) probably have a better prognosis and less frequently involve regional lymph nodes than other melanomas. Regressed melanoma. If the lesion is on the back or posterior shoulder a history of a previous lesion may be unavailable. Key features are: 1. Epidermal thinning with loss of rete ridges. 2. Minimal or absent atypical junctional change.

8 3. A subepidermal band of angiofibroplasia (often up to 0.8mm thick) which may variably contain a few lymphocytes, melanophages and an occasional melanocyte. Capillaries are usually slightly increased. Melanoma Pathology Report The report should include all factors that affect accurate diagnosis, management and prognosis Currently the most important pathological prognostic factors for clinically localized primary melanoma are tumour thickness (Breslow), dermal mitotic rate (which also influences the rate of sentinel lymph node positivity) and ulceration. 1, Other factors are Clark level, site (trunk worse than extremities), age and gender (males worse than females). Margins of Excision. These are important in determining further management of atypical melanocytic lesions and melanomas. The main problem is accurately assessing the margins of lentigo maligna (Hutchinson s melanotic freckle) and some other melanocytic tumours where atypical melanocytes trail off at the edges. 32 To avoid excessive excisions, a marginal excision around the clinically affected area is usually done initially for definitive diagnosis. Wider excision (as per current melanoma treatment guidelines) can then be performed once a diagnosis of melanoma has been confirmed. # Adapted from McCarthy SW, Scolyer RA. Pitfalls and Important Issues in the Pathologic Diagnosis of Melanocytic Tumors. The Ochsner Journal 2010 (in press). REFERENCES 1. Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma.[see comment]. Lancet 2005;365(9460): Murali R, Thompson JF, Scolyer RA. Sentinel lymph node biopsy for melanoma: aspects of pathologic assessment. Future Oncology 2008;4(4): Scolyer RA, McCarthy SW, Elder DE. Frontiers in melanocytic pathology. Pathology 2004;36(5): Scolyer RA, Thompson JF, McCarthy SW, Strutton GM, Elder DE. Incomplete biopsy of melanocytic lesions can impair the accuracy of pathological diagnosis.[erratum appears in Australas J Dermatol Nov;47(4):308]. Australasian Journal of Dermatology 2006;47(1):71-3; author reply Scolyer RA, Thompson JF, Stretch JR, Sharma R, McCarthy SW. Pathology of melanocytic lesions: new, controversial, and clinically important issues. Journal of Surgical Oncology 2004;86(4): Murali R, Sharma RN, Thompson JF, Stretch JR, Lee CS, McCarthy SW, et al. Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors). Annals of Surgical Oncology 2008;15(1): Morey AL, Murali R, McCarthy SW, Mann GJ, Scolyer RA. Diagnosis of cutaneous melanocytic tumours by fourcolour fluorescence in situ hybridisation. Pathology 2009;41(4): Huang SK, Darfler MM, Nicholl MB, You J, Bemis KG, Tegeler TJ, et al. LC/MS-based quantitative proteomic analysis of paraffin-embedded archival melanomas reveals potential proteomic biomarkers associated with metastasis. PLoS One 2009;4(2):e McCarthy SW, Scolyer RA, Palmer AA. Desmoplastic melanoma: a diagnostic trap for the unwary. Pathology 2004;36(5): Scolyer RA, Thompson JF. Desmoplastic melanoma: a heterogeneous entity in which subclassification as "pure" or "mixed" may have important prognostic significance.[comment]. Annals of Surgical Oncology 2005;12(3): Crotty KA, Scolyer RA, Li L, Palmer AA, Wang L, McCarthy SW. Spitz naevus versus Spitzoid melanoma: when and how can they be distinguished?[see comment]. Pathology 2002;34(1): Shaw HM, Quinn MJ, Scolyer RA, Thompson JF. Survival in patients with desmoplastic melanoma.[comment]. Journal of Clinical Oncology 2006;24(8):e12; author reply e Thompson JF, Scolyer RA. Cooperation between surgical oncologists and pathologists: a key element of multidisciplinary care for patients with cancer. Pathology 2004;36(5):

9 14. McCarthy SW, Scolyer RA. Melanocytic lesions of the face: diagnostic pitfalls. Annals of the Academy of Medicine, Singapore 2004;33(4 Suppl): Murali R, McCarthy SW, Thompson JF, Scolyer RA. Melanocytic nevus with focal atypical epithelioid components (clonal nevus) is a combined nevus.[comment]. Journal of the American Academy of Dermatology 2007;56(5): Scolyer RA, Zhuang L, Palmer AA, Thompson JF, McCarthy SW. Combined naevus: a benign lesion frequently misdiagnosed both clinically and pathologically as melanoma. Pathology 2004;36(5): Murali R, McCarthy SW, Scolyer RA. Blue nevi and related lesions: a review highlighting atypical and newly described variants, distinguishing features and diagnostic pitfalls. Adv Anat Pathol 2009;16(6): Mandal RV, Murali R, Lundquist KF, Ragsdale BD, Heenan P, McCarthy SW, et al. Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up. Am J Surg Pathol 2009;33(12): Dahlstrom JE, Scolyer RA, Thompson JF, Jain S. Spitz naevus: diagnostic problems and their management implications. Pathology 2004;36(5): Busam KJ, Murali R, Pulitzer M, McCarthy SW, Thompson JF, Shaw HM, et al. Atypical spitzoid melanocytic tumors with positive sentinel lymph nodes in children and teenagers, and comparison with histologically unambiguous and lethal melanomas. Am J Surg Pathol 2009;33(9): Scolyer RA, Murali R, McCarthy SW, Thompson JF. Pathologic examination of sentinel lymph nodes from melanoma patients. Semin Diagn Pathol 2008;25(2): Chakera AH, Hesse B, Burak Z, Ballinger JR, Britten A, Caraco C, et al. EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging 2009;36(10): Karim RZ, van den Berg KS, Colman MH, McCarthy SW, Thompson JF, Scolyer RA. The advantage of using a synoptic pathology report format for cutaneous melanoma. Histopathology 2008;52(2): Azzola MF, Shaw HM, Thompson JF, Soong S-J, Scolyer RA, Watson GF, et al. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center. Cancer 2003;97(6): Francken AB, Shaw HM, Thompson JF, Soong S-j, Accortt NA, Azzola MF, et al. The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up.[see comment]. Annals of Surgical Oncology 2004;11(4): Scolyer RA, Shaw HM, Thompson JF, Li L-XL, Colman MH, Lo SK, et al. Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. American Journal of Surgical Pathology 2003;27(12): Scolyer RA, Thompson JF, Shaw HM, McCarthy SW. The importance of mitotic rate as a prognostic factor for localized primary cutaneous melanoma.[comment]. Journal of Cutaneous Pathology 2006;33(5):395-6; author reply Thompson JF, Scolyer RA, Kefford RF, Uren RF. Melanoma management in 2007.[comment]. Australian Family Physician 2007;36(7):487-8; author reply Thompson JF, Shaw HM, Hersey P, Scolyer RA. The history and future of melanoma staging. Journal of Surgical Oncology 2004;86(4): Murali R, Hughes MT, Fitzgerald P, Thompson JF, Scolyer RA. Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma. Ann Surg 2009;249(4): Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma in the era of molecular profiling. Lancet 2009;374(9687): Stretch JR, Scolyer RA. Surgical strategies and histopathologic issues in the management of lentigo maligna. Ann Surg Oncol 2009;16(6): Van Es SL, Colman M, Thompson JF, McCarthy SW, Scolyer RA. Angiotropism is an independent predictor of local recurrence and in-transit metastasis in primary cutaneous melanoma. Am J Surg Pathol 2008;32(9): Ng JC, Swain S, Dowling JP, Wolfe R, Simpson P, Kelly JW. The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma: experience of an Australian tertiary referral service. Archives of Dermatology 2010;146(3):234-9.

David B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma

David B. Troxel, MD. Common Medicolegal Situations: Misdiagnosis of Melanoma Common Medicolegal Situations: Misdiagnosis of Melanoma David B. Troxel, MD Medical Director, The Doctors Company, Napa, California Clinical Professor Emeritus, University of California at Berkeley Past

More information

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL

A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL A PRACTICAL APPROACH TO ATYPICAL MELANOCYTIC LESIONS BIJAN HAGHIGHI M.D, DIRECTOR OF DERMATOPATHOLOGY, ST. JOSEPH HOSPITAL OBJECTIVES Discuss current trends and changing concepts in our understanding of

More information

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC R/O BCC Sabine Kohler, M.D. Professor of Pathology and Dermatology Dermatopathology Service Stanford University School of Medicine Clinical Information 74 y.o. man with lesion on left side of neck r/o

More information

Dermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia

Dermatopathology. Dr. Rafael Botella Estrada. Hospital La Fe de Valencia Dermatopathology Dr. Rafael Botella Estrada. Hospital La Fe de Valencia Melanoma and mimics Dr. Martin Mihm Malignant lesions result from the accumulation of mutations Class I lesions (benign) Class II

More information

Female 18. Deeply pigmented lesion on trunk.?warty naevus?seborrhoeic keratosis?malignant melanoma. The best diagnosis is:

Female 18. Deeply pigmented lesion on trunk.?warty naevus?seborrhoeic keratosis?malignant melanoma. The best diagnosis is: Female 18. Deeply pigmented lesion on trunk.?warty naevus?seborrhoeic keratosis?malignant melanoma. The best diagnosis is: A. deep penetrating naevus B. naevoid malignant melanoma C. pigment synthesising

More information

Case 26 Male 37. Right jawline 5mm nodule?keloid. The best diagnosis is:

Case 26 Male 37. Right jawline 5mm nodule?keloid. The best diagnosis is: Case 26 Male 37. Right jawline 5mm nodule?keloid. The best diagnosis is: A. Desmoplastic Spitz naevus B. Atypical Spitz Tumour C. Spitzoid melanoma D. Deep penetrating naevus E. Spitz naevus Case 26: M

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,500 108,000 1.7 M Open access books available International authors and editors Downloads Our

More information

Associate Clinical Professor of Dermatology MUSC

Associate Clinical Professor of Dermatology MUSC Re-excision of Moderately Dysplastic Nevi: Should we or shouldn t we? John C. Maize, Jr, M.D. Dermatologist and Dermatopathologist Trident Dermatology, Charleston SC Associate Clinical Professor of Dermatology

More information

Melanoma Update: 8th Edition of AJCC Staging System

Melanoma Update: 8th Edition of AJCC Staging System Melanoma Update: 8th Edition of AJCC Staging System Rosalie Elenitsas, M.D. Professor of Dermatology Director, Dermatopathology University of Pennsylvania DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY None

More information

Paediatric Dermatology Column: Case Report. Paediatric melanoma: challenges in diagnosis and management

Paediatric Dermatology Column: Case Report. Paediatric melanoma: challenges in diagnosis and management Hong Kong J. Dermatol. Venereol. (2014) 22, 30-34 Paediatric Dermatology Column: Case Report Paediatric melanoma: challenges in diagnosis and management M Liu, CJA Henderson, M Gupta Paediatric melanoma,

More information

FORUM. Collaboration between clinicians and pathologists: a necessity for the optimal management of melanoma patients

FORUM. Collaboration between clinicians and pathologists: a necessity for the optimal management of melanoma patients Collaboration between clinicians and pathologists: a necessity for the optimal management of melanoma patients Richard Scolyer, 1,2 John Thompson, 1,3 Jonathan Stretch, 1,3 Stanley McCarthy 1,2 1 Sydney

More information

Melanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media

Melanoma and Dermoscopy. Disclosure Statement: ABCDE's of melanoma. Co-President, Usatine Media Melanoma and Dermoscopy Richard P. Usatine, MD, FAAFP Professor, Family and Community Medicine Professor, Dermatology and Cutaneous Surgery Medical Director, University Skin Clinic University of Texas

More information

Histopathology of Melanoma

Histopathology of Melanoma THE YALE JOURNAL OF BIOLOGY AND MEDICINE 48, 409-416 (1975) Histopathology of Melanoma G. J. WALKER SMITH Department ofpathology, Yale University School ofmedicine, 333 Cedar Street, New Haven, Connecticut

More information

Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more

Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more Benign and malignant epithelial lesions: Seborrheic keratosis: A common benign pigmented epidermal tumor occur in middle-aged or older persons more common on the trunk; but extremities, head and neck are

More information

Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc

Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc 1 Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc Benign lesions Seborrheic Keratoses: Warty, stuck-on Genetics and birthdays Can start in late

More information

المركب النموذج--- سبيتز وحمة = Type Spitz's Nevus, Compound SPITZ NEVUS 1 / 7

المركب النموذج--- سبيتز وحمة = Type Spitz's Nevus, Compound SPITZ NEVUS 1 / 7 SPITZ NEVUS 1 / 7 Epidemiology An annual incidence rate of 1.4 cases of Spitz nevus per 100,000 individuals has been estimated in Australia, compared with 25.4 per 100,000 individuals for cutaneous melanoma

More information

Melanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG

Melanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG Melanoma-Back to Basics I Thought I Knew Ya! Paul K. Shitabata, M.D. Dermatopathologist APMG At tumor board, a surgeon insists that all level II melanomas are invasive since they have broken through the

More information

5/21/2018. Disclosures. Consulting: Myriad Genetics SciBase. Superficial Atypical Melanocytic Proliferations. SSM, LMM and (some of) their Simulants

5/21/2018. Disclosures. Consulting: Myriad Genetics SciBase. Superficial Atypical Melanocytic Proliferations. SSM, LMM and (some of) their Simulants Disclosures Consulting: Myriad Genetics SciBase Superficial Atypical Melanocytic Proliferations SSM, LMM and (some of) their Simulants 1 Melanomas and Nevi. Nevi are important mainly in relation to melanoma

More information

Protocol applies to melanoma of cutaneous surfaces only.

Protocol applies to melanoma of cutaneous surfaces only. Melanoma of the Skin Protocol applies to melanoma of cutaneous surfaces only. Procedures Biopsy (No Accompanying Checklist) Excision Re-excision Protocol revision date: January 2005 Based on AJCC/UICC

More information

Pathology of the skin. 2nd Department of Pathology, Semmelweis University

Pathology of the skin. 2nd Department of Pathology, Semmelweis University Pathology of the skin 2nd Department of Pathology, Semmelweis University Histology of the skin Epidermis: Stratum corneum Stratum granulosum Stratum spinosum Stratum basale Dermis: papillary and reticular

More information

Histopathology: skin pathology

Histopathology: skin pathology Histopathology: skin pathology These presentations are to help you identify, and to test yourself on identifying, basic histopathological features. They do not contain the additional factual information

More information

Primary Cutaneous Melanoma Pathology Reporting Proforma DD MM YYYY. *Tumour site. *Specimen laterality. *Specimen type

Primary Cutaneous Melanoma Pathology Reporting Proforma DD MM YYYY. *Tumour site. *Specimen laterality. *Specimen type Primary Cutaneous Melanoma Pathology Reporting Proforma Includes the International Collaboration on Cancer reporting dataset denoted by * Family name Given name(s) Date of birth DD MM YYYY Sex Male Female

More information

K Blessing, J J H Grant, D S A Sanders, M M Kennedy, A Husain, P Coburn

K Blessing, J J H Grant, D S A Sanders, M M Kennedy, A Husain, P Coburn J Clin Pathol 2000;53:591 595 591 Papers Pathology, Aberdeen University, Foresterhill, Aberdeen AB25 2ZD, K Blessing Pathology, Birmingham University, Birmingham B15 2TT, D S A Sanders Pathology, Heartlands

More information

Malignant tumors of melanocytes: Part 1. Deba P Sarma, MD., Omaha

Malignant tumors of melanocytes: Part 1. Deba P Sarma, MD., Omaha Malignant tumors of melanocytes: Part 1 Deba P Sarma, MD., Omaha The melanocytic tumor is one of the most difficult and confusing areas in Dematopathology. It is true that most (95%) of such lesions are

More information

Melanoma Underwriting Presented at 2018 AHOU Conference. Hank George FALU

Melanoma Underwriting Presented at 2018 AHOU Conference. Hank George FALU Melanoma Underwriting Presented at 2018 AHOU Conference Hank George FALU MELANOMA EPIDEMIOLOGY 70-80,000 American cases annually Majority are in situ or thin > 20% are diagnosed age 45 8-9,000 melanoma

More information

Dr. Brent Doolan, BSc MBBS MPH

Dr. Brent Doolan, BSc MBBS MPH Impact of partial biopsies on the need for complete excisional surgery in the management of cutaneous melanomas: A multi-centre review Dr. Brent Doolan, BSc MBBS MPH Peter MacCallum Cancer Centre, Melbourne

More information

Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma. Cutaneous Melanoma: Epidemiology (USA)

Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma. Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma Cutaneous Melanoma: Epidemiology (USA) 6 th leading cause of cancer among men and women 68,720 new cases of invasive melanoma in 2009 8,650 deaths from melanoma

More information

Melanocytic Lesions: Use of Immunohistochemistry and Special Studies Napa Valley 2018

Melanocytic Lesions: Use of Immunohistochemistry and Special Studies Napa Valley 2018 Melanocytic Lesions: Use of Immunohistochemistry and Special Studies Napa Valley 2018 Victor G. Prieto, MD, PhD Professor Depts. of Pathology and Dermatology University of Texas - MD Anderson Cancer Center

More information

Multiple Primary Melanoma in a Thai Male: A Case Report

Multiple Primary Melanoma in a Thai Male: A Case Report Case Report Multiple Primary Melanoma in a Thai Male: A Case Report J Med Assoc Thai 2014; 97 (Suppl. 2): S234-S238 Full text. e-journal: http://www.jmatonline.com Kittisak Payapvipapong MD*, Pinyapat

More information

Dermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.

Dermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses. Squamous cell carcinoma (SCC): A common malignant tumor of keratinocytes arising in the epidermis, usually from a precancerous condition: 1- UV induced actinic keratosis, usually of low grade malignancy.

More information

EARLY ONLINE RELEASE

EARLY ONLINE RELEASE EARLY ONLINE RELEASE Note: This article was posted on the Archives Web site as an Early Online Release. Early Online Release articles have been peer reviewed, copyedited, and reviewed by the authors. Additional

More information

Diagnoses of Cases 1. Lentigo, other melanosis and the acquired nevus 2. Variations on the acquired nevus 3. Dermal melanocytosis

Diagnoses of Cases 1. Lentigo, other melanosis and the acquired nevus 2. Variations on the acquired nevus 3. Dermal melanocytosis Diagnoses of Cases 1. Lentigo, other melanosis and the acquired nevus 1 1A. Lentigo simplex 4 1B. Psoralens and ultraviolet A (PUVA) lentigo 6 1C. Solar lentigo 8 1D. Café au lait macule 10 1E. Ink-spot

More information

Conflict of Interest 9/2/2014. Pathogenesis and Comparison of Atypical Spitz Nevi vs Benign Spitz, and Childhood Melanoma

Conflict of Interest 9/2/2014. Pathogenesis and Comparison of Atypical Spitz Nevi vs Benign Spitz, and Childhood Melanoma Pathogenesis and Comparison of Atypical Spitz Nevi vs Benign Spitz, and Childhood Melanoma Martin C. Mihm Jr., M.D., F.A.C.P. Harvard Medical School Brigham and Women s Hospital Dana Farber Cancer Center

More information

Ways to get into trouble, ideas on avoiding trouble, and diagnostic approaches to keep trouble at bay

Ways to get into trouble, ideas on avoiding trouble, and diagnostic approaches to keep trouble at bay Pitfalls in the diagnosis of melanocytic tumors Timothy McCalmont, MD University of California, San Francisco Ways to get into trouble, ideas on avoiding trouble, and diagnostic approaches to keep trouble

More information

Management of pediatric melanocytic lesions

Management of pediatric melanocytic lesions Open Journal of Clinical & Medical Case Reports Management of pediatric melanocytic lesions Volume 3 (2017) Issue 8 ISSN 2379-1039 Jin Kim, BS; Emmanuel Gabriel MD, PhD; Weiguo Liu MD, PhD; Lin Lin MD,

More information

Update on 8 th Edition Cutaneous AJCC Staging of Primary Cutaneous Melanoma. Michael T. Tetzlaff MD, PhD

Update on 8 th Edition Cutaneous AJCC Staging of Primary Cutaneous Melanoma. Michael T. Tetzlaff MD, PhD Update on 8 th Edition Cutaneous AJCC Staging of Primary Cutaneous Melanoma Michael T. Tetzlaff MD, PhD Associate Professor Departments of Pathology (Dermatopathology) and Translational and Molecular Pathology

More information

أملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5

أملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5 Leiomyosarcoma 1 / 5 EPIDEMIOLOGY Exact incidence is unknown, but older studies suggest that leiomyosarcomas comprise approximately 3 percent of soft-tissue sarcomas. Superficial leiomyosarcoma occurs

More information

Basal cell carcinoma 5/28/2011

Basal cell carcinoma 5/28/2011 Goal of this Presentation A practical approach to the diagnosis of cutaneous carcinomas and their mimics Thaddeus Mully, MD University of California San Francisco To review common non-melanoma skin cancers

More information

Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha

Malignant tumors of melanocytes : Part 3. Deba P Sarma, MD., Omaha Malignant tumors of melanocytes : Part 3 Deba P Sarma, MD., Omaha Let s go over one case of melanoma using the following worksheet. Of the various essential information that needs to be included in the

More information

Guy Perrot (Ги Перро)

Guy Perrot (Ги Перро) НАУЧНО-ПРАКТИЧЕСКАЯ КОНФЕРЕНЦИЯ (МАСТЕР-КЛАСС) «ПРАКТИЧЕСКИЕ АСПЕКТЫ ДИАГНОСТИКИ И ЛЕЧЕНИЯ МЕЛАНОМЫ КОЖИ» DIAGNOSTIC AND PITFALLS IN MELANOMA Guy Perrot (Ги Перро) MD PHD pathologist, University Hospital

More information

Epithelial Cancer- NMSC & Melanoma

Epithelial Cancer- NMSC & Melanoma Epithelial Cancer- NMSC & Melanoma David Chin MB, BCh, BAO, LRCP, LRCS (Ireland) MCh(MD), PhD (UQ), FRCS, FRACS (Plast) Plastic & Reconstructive Surgeon Visiting Scientist Melanoma Genomic Group & Drug

More information

F006 Imaging in Dermatology Melanocytic Neoplasia Clinical-Confocal-Pathological-Correlations

F006 Imaging in Dermatology Melanocytic Neoplasia Clinical-Confocal-Pathological-Correlations F006 Imaging in Dermatology Melanocytic Neoplasia Clinical-Confocal-Pathological-Correlations Melissa Gill, MD SkinMedical Research and Diagnostics Dobbs Ferry, NY, USA Department of Pathology SUNY Downstate

More information

Citation for published version (APA): Niebling, M. G-J. (2014). Improving Staging Accuracy in Melanoma Groningen: s.n.

Citation for published version (APA): Niebling, M. G-J. (2014). Improving Staging Accuracy in Melanoma Groningen: s.n. University of Groningen Improving Staging Accuracy in Melanoma Niebling, Maarten Gert-Jan IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it.

More information

1/10/2018. Soft Tissue Tumors Showing Melanocytic Differentiation. Overview. Desmoplastic/ Spindle Cell Melanoma

1/10/2018. Soft Tissue Tumors Showing Melanocytic Differentiation. Overview. Desmoplastic/ Spindle Cell Melanoma 2016 MFMER slide-1 2016 MFMER slide-2 2016 MFMER slide-3 Soft Tissue Tumors Showing Melanocytic Differentiation Andrew L. Folpe, M.D. Professor of Laboratory Medicine and Pathology Mayo Clinic, Rochester,

More information

Springer Healthcare. Staging and Diagnosing Cutaneous Melanoma. Concise Reference. Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone

Springer Healthcare. Staging and Diagnosing Cutaneous Melanoma. Concise Reference. Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone Concise Reference Staging and Diagnosing Cutaneous Melanoma Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone Extracted from Handbook of Cutaneous Melanoma: A Guide to Diagnosis and Treatment Published

More information

Polypoid Melanoma, A Virulent Variant of the Nodular Growth Pattern

Polypoid Melanoma, A Virulent Variant of the Nodular Growth Pattern Polypoid Melanoma, A Virulent Variant of the Nodular Growth Pattern ELIZABETH A. MANCI, M.D., CHARLES M. BALCH, M.D..TARIQ M. MURAD, M.D., PH.D., AND SENG/JAW SOONG, PH.D. Manci, Elizabeth A., Balch, Charles

More information

Case RAC7783. M46. Ear. Mole. r/o MM.?Blue naevus RAC7783

Case RAC7783. M46. Ear. Mole. r/o MM.?Blue naevus RAC7783 Case RAC7783. M46. Ear. Mole. r/o MM.?Blue naevus RAC7783 Pie Chart Participants N=74 Benign: 48 N=74 Blue naevus: 38 Intradermal: 12 DPN: 10 Compound 3 Clonal: 3; Spitz 2; Special Site: 1; Congenital:

More information

Clinical characteristics

Clinical characteristics Skin Cancer Fernando Vega, MD Seattle Healing Arts Clinical characteristics Precancerous lesions Common skin cancers ACTINIC KERATOSIS Precancerous skin lesions Actinic keratoses Dysplastic melanocytic

More information

Simulators of melanoma

Simulators of melanoma Simulators of melanoma Philip E. LeBoit, M.D. Depts. of Pathology and Dermatology University of California, San Francisco Simulators of melanoma Simulators of melanoma in situ Melanocytic Non-melanocytic

More information

6/22/2015. Original Paradigm. Correlating Histology and Molecular Findings in Melanocytic Neoplasms

6/22/2015. Original Paradigm. Correlating Histology and Molecular Findings in Melanocytic Neoplasms 6 Correlating Histology and Molecular Findings in Melanocytic Neoplasms Pedram Gerami MD, Associate Professor of Dermatology and Pediatrics at Northwestern University Disclosures: I have been a consultant

More information

Less Common Variants of Cutaneous Melanoma

Less Common Variants of Cutaneous Melanoma Less Common Variants of Cutaneous Melanoma Raymond L. Barnhill* 1, G. Peter Sarantopoulos 1, and Kapil Gupta 2 1 Department of Pathology and Laboratory Medicine, University of California, Los Angeles,

More information

IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY

IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY IT S FUNDAMENTAL MY DEAR WATSON! A SHERLOCKIAN APPROACH TO DERMATOLOGY Skin, Bones, and other Private Parts Symposium Dermatology Lectures by Debra Shelby, PhD, DNP, FNP-BC, FADNP, FAANP Debra Shelby,

More information

S everal morphological features are frequently used in the

S everal morphological features are frequently used in the 1194 ORIGINAL ARTICLE Interobserver reproducibility of histological features in cutaneous malignant melanoma C Urso, F Rongioletti, D Innocenzi, C Saieva, D Batolo, S Chimenti, R Filotico, R Gianotti,

More information

Dermatologica Sinica

Dermatologica Sinica DERMATOLOGICA SINICA 30 (2012) 57e61 Contents lists available at SciVerse ScienceDirect Dermatologica Sinica journal homepage: http://www.derm-sinica.com CASE REPORT Pigmented epithelioid melanocytoma:

More information

STUDY. The Impact of Partial Biopsy on Histopathologic Diagnosis of Cutaneous Melanoma

STUDY. The Impact of Partial Biopsy on Histopathologic Diagnosis of Cutaneous Melanoma STUDY The Impact of Partial Biopsy on Histopathologic Diagnosis of Cutaneous Melanoma Experience of an Australian Tertiary Referral Service Jonathan C. Ng, MBBS, MBiomedSc; Sarah Swain, MBBS, FRCPA; John

More information

An Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center

An Overview of Melanoma. Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center An Overview of Melanoma Harriet Kluger, M.D. Associate Professor Section of Medical Oncology Yale Cancer Center Melanoma Statistics Median age at presentation 45-55 55 years Incidence: 2003 54,200 cases

More information

Interesting Case Series. Desmoplastic Melanoma

Interesting Case Series. Desmoplastic Melanoma Interesting Case Series Desmoplastic Melanoma Anthony Maurice Kordahi, MD, Joshua B. Elston, MD, Ellen M. Robertson, MD, and C. Wayne Cruse, MD Division of Plastic Surgery, Department of Surgery, University

More information

Melanoma. Kaushik Mukherjee MD A. Scott Pearson MD

Melanoma. Kaushik Mukherjee MD A. Scott Pearson MD Melanoma Kaushik Mukherjee MD A. Scott Pearson MD Disclosures You still have to study Not all inclusive No Western blots Extensive use of Google Image Search and Sabiston Melanoma Basics 8 th most common

More information

Desmoplastic Melanoma: Clinical Behavior and Management Implications

Desmoplastic Melanoma: Clinical Behavior and Management Implications Desmoplastic Melanoma: Clinical Behavior and Management Implications Collier S. Pace, MD, a Jyoti P. Kapil, MD, b Luke G. Wolfe, MS, c Brian J. Kaplan, MD, c and James P. Neifeld, MD c a Division of Plastic

More information

Michael T. Tetzlaff MD, PhD

Michael T. Tetzlaff MD, PhD Molecular alterations informing the diagnosis of melanocytic tumors Michael T. Tetzlaff MD, PhD Associate Professor Department of Pathology, Section of Dermatopathology Department of Translational and

More information

Contrast with Australian Guidelines A/Pr Pascale Guitera,

Contrast with Australian Guidelines A/Pr Pascale Guitera, Contrast with Australian Guidelines A/Pr Pascale Guitera, Dermatologist, Sydney University NO CONFLICT OF INTEREST Sydney Melanoma Diagnostic Centre, RPAH 2011 2008 225 pages 16 pages http://www.cancer.org.au/file/healthprofessionals/clinica

More information

There is NO single Melanoma Stain. > 6000 Mutations in Melanoma. What else can be done to discriminate atypical nevi from melanoma?

There is NO single Melanoma Stain. > 6000 Mutations in Melanoma. What else can be done to discriminate atypical nevi from melanoma? Las Vegas Fall Clinical 2016: The Assessment and Diagnosis of Melanoma Whitney A. High, MD, JD, MEng Associate Professor, Dermatology & Pathology Director of Dermatopathology (Dermatology) University of

More information

Update on Spitzoid and Blue nevus-like melanocytic lesions Emphasis on molecular studies informing diagnosis, prognosis and therapy

Update on Spitzoid and Blue nevus-like melanocytic lesions Emphasis on molecular studies informing diagnosis, prognosis and therapy Update on Spitzoid and Blue nevus-like melanocytic lesions Emphasis on molecular studies informing diagnosis, prognosis and therapy Michael T. Tetzlaff MD, PhD Associate Professor Department of Pathology,

More information

Toby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma

Toby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma Distinguishing Pigmented Skin Lesions and Melanoma Toby Maurer, MD University of California, San Francisco Epidemiology of Melanoma Lifetime risk of an American developing melanoma 1935: 1 in 1500 1980:

More information

The Relevance of Cytologic Atypia in Cutaneous Neural Tumors

The Relevance of Cytologic Atypia in Cutaneous Neural Tumors The Relevance of Cytologic Atypia in Cutaneous Neural Tumors Recent Findings - New Developments New Problems Zsolt B. Argenyi, M.D. Professor of Pathology & Dermatology Director of Dermatopathology Department

More information

The Enigmatic Spitz Lesion

The Enigmatic Spitz Lesion The Enigmatic Spitz Lesion The Dawn of Spitz S Spitz Sophie Spitz Melanomas of Childhood ; Am J Pathol 1948 1910-1956 13 children (18 mo - 12 yrs) 12/13 had a benign clinical course Sophie Spitz Born 1910

More information

Published Ahead of Print on December 14, 2009 as /JCO J Clin Oncol by American Society of Clinical Oncology

Published Ahead of Print on December 14, 2009 as /JCO J Clin Oncol by American Society of Clinical Oncology Published Ahead of Print on December 14, 2009 as 10.1200/JCO.2009.24.7734 The latest version is at http://jco.ascopubs.org/cgi/doi/10.1200/jco.2009.24.7734 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L

More information

Case Report Micromelanomas: A Review of Melanomas 2mmand a Case Report

Case Report Micromelanomas: A Review of Melanomas 2mmand a Case Report Case Reports in Oncological Medicine, Article ID 206260, 4 pages http://dx.doi.org/10.1155/2014/206260 Case Report Micromelanomas: A Review of Melanomas 2mmand a Case Report Sharad P. Paul 1,2,3 1 Skin

More information

Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival

Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival MOLECULAR AND CLINICAL ONCOLOGY 7: 1083-1088, 2017 Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival FARUK TAS

More information

Selected Pseudomalignant Soft Tissue Tumors of the Skin and Subcutis

Selected Pseudomalignant Soft Tissue Tumors of the Skin and Subcutis Selected Pseudomalignant Soft Tissue Tumors of the Skin and Subcutis Andrew L. Folpe, M.D. Professor of Laboratory Medicine and Pathology Mayo Clinic, Rochester, MN folpe.andrew@mayo.edu 2016 MFMER slide-1

More information

Melanoma and the genes: Molecular alterations informing the diagnosis of melanocytic tumors

Melanoma and the genes: Molecular alterations informing the diagnosis of melanocytic tumors Melanoma and the genes: Molecular alterations informing the diagnosis of melanocytic tumors Michael T. Tetzlaff MD, PhD Associate Professor Department of Pathology, Section of Dermatopathology Department

More information

Updates on Melanoma: Are You Following the Latest Guidelines of Care? Jerry Brewer, MD

Updates on Melanoma: Are You Following the Latest Guidelines of Care? Jerry Brewer, MD Updates on Melanoma: Are You Following the Latest Guidelines of Care? Jerry Brewer, MD Disclosure Statement Update on Melanoma Are You Following the Latest Guidelines of Care? I, Jerry D. Brewer, MD, do

More information

Toby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma

Toby Maurer, MD University of California, San Francisco. Lifetime risk of an American developing melanoma Distinguishing Pigmented Skin Lesions and Melanoma Toby Maurer, MD University of California, San Francisco Epidemiology of Melanoma Lifetime risk of an American developing melanoma 1935: 1 in 1500 1980:

More information

Maligna Melanoma and Atypical Fibroxanthoma: An Unusual Collision Tumour G Türkcü 1, A Keleş 1, U Alabalık 1, D Uçmak 2, H Büyükbayram 1 ABSTRACT

Maligna Melanoma and Atypical Fibroxanthoma: An Unusual Collision Tumour G Türkcü 1, A Keleş 1, U Alabalık 1, D Uçmak 2, H Büyükbayram 1 ABSTRACT Maligna Melanoma and Atypical Fibroxanthoma: An Unusual Collision Tumour G Türkcü 1, A Keleş 1, U Alabalık 1, D Uçmak 2, H Büyükbayram 1 ABSTRACT Two different neoplasia in the same biopsy material called

More information

Genetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology

Genetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology Genetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology Outline Germline testing CDKN2A BRCA2 BAP1 Somatic testing Gene expression profiling (GEP) BRAF Germline vs Somatic testing

More information

Identifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018

Identifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018 Identifying Skin Cancer Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018 American Cancer Society web site Skin Cancer Melanoma Non-Melanoma

More information

Dysplasia, Mimics and Other Controversies

Dysplasia, Mimics and Other Controversies Dysplasia, Mimics and Other Controversies Mary S. Richardson, MD Dept. of Pathology Medical University of South Carolina Charleston, SC Notice of Faculty Disclosure In accordance with ACGME guidelines,

More information

WHAT DOES THE PATHOLOGY REPORT MEAN?

WHAT DOES THE PATHOLOGY REPORT MEAN? Melanoma WHAT IS MELANOMA? Melanoma is a type of cancer that affects cells called melanocytes. These cells are found mainly in skin but also in the lining of other areas such as nose and rectum, and also

More information

PATHOLOGY OF THE SKIN 2. Tumours of the skin

PATHOLOGY OF THE SKIN 2. Tumours of the skin PATHOLOGY OF THE SKIN 2. Tumours of the skin Máirín E. McMenamin MB MRCPI FRCPath Dip (Dermatopathol) RCPath St. James s Hospital and University of Dublin, Trinity College Tumour (Neoplasia) Benign or

More information

Desmoplastic Melanoma: Surgical Management and Adjuvant Therapy

Desmoplastic Melanoma: Surgical Management and Adjuvant Therapy Desmoplastic Melanoma: Surgical Management and Adjuvant Therapy Dale Han, MD Assistant Professor Department of Surgery Section of Surgical Oncology No disclosures Background Desmoplastic melanoma (DM)

More information

Update on Cutaneous Mesenchymal Tumors. Thomas Brenn

Update on Cutaneous Mesenchymal Tumors. Thomas Brenn Update on Cutaneous Mesenchymal Tumors Thomas Brenn Cutaneous Mesenchymal Tumours Wide morphological and biological spectrum Myofibroblastic, smooth muscle, neural, vascular, apidocytic, undifferentiated;

More information

Vernon K. Sondak. Department of Cutaneous Oncology Moffitt Cancer Center Tampa, Florida

Vernon K. Sondak. Department of Cutaneous Oncology Moffitt Cancer Center Tampa, Florida Vernon K. Sondak Department of Cutaneous Oncology Moffitt Cancer Center Tampa, Florida Australasian Melanoma Conference 2016 Sydney, NSW, Australia October 29, 2016 Disclosures Dr. Sondak is a compensated

More information

Blue Melanocytic Proliferations

Blue Melanocytic Proliferations Blue Melanocytic Proliferations Labib R. Zakka M.D., M.A. Research Fellow Melanoma Program Department of Dermatology Brigham and Women s Hospital Harvard Medical School Conflicts of Interest No conflicts

More information

ORAL MELANOMA Definition Epidemiology Clinical Presentation

ORAL MELANOMA Definition Epidemiology Clinical Presentation ORAL MELANOMA Definition Melanoma is a highly malignant neoplasia, arising from melanocytes, the cells that produce the brownish pigment melanin. Melanin is the determinant in skin colour and protects

More information

Atypical Nevi When to Re-excise. Catherine Barry, DO Dermatopathologist

Atypical Nevi When to Re-excise. Catherine Barry, DO Dermatopathologist Atypical Nevi When to Re-excise Catherine Barry, DO Dermatopathologist Why talk about skin cancer? Because it s the most common type of cancer! Non-melanoma Skin Cancers Basal Cell Carcinoma Squamous Cell

More information

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath Neoplasia 2018 Lecture 2 Dr Heyam Awad MD, FRCPath ILOS 1. List the differences between benign and malignant tumors. 2. Recognize the histological features of malignancy. 3. Define dysplasia and understand

More information

Lichenoid Tissue Reaction in Malignant Melanoma A Potential Diagnostic Pitfall

Lichenoid Tissue Reaction in Malignant Melanoma A Potential Diagnostic Pitfall natomic Pathology / LICHENOID TISSUE RECTION IN MLIGNNT MELNOM Lichenoid Tissue Reaction in Malignant Melanoma Potential Diagnostic Pitfall CPT Scott R. Dalton, MC, US, 1,3 Capt Matt. aptista, USF, MC,

More information

NAACCR Webinar Series 1

NAACCR Webinar Series 1 Collecting Cancer Data: Melanoma 2013 2014 NAACCR Webinar Series April 3, 2014 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching

More information

Michael T. Tetzlaff MD, PhD

Michael T. Tetzlaff MD, PhD Update on American Joint Cancer Committee (AJCC) staging system for primary cutaneous melanoma Emphasis on concise and accurate reporting of primary and metastatic melanoma for effective risk stratification

More information

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 12, :30 am 11:00 am

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB. Friday, February 12, :30 am 11:00 am MECHANISMS OF HUMAN DISEASE: LABORATORY SESSION PATHOLOGY OF THE SKIN LAB Friday, February 12, 2012 9:30 am 11:00 am FACULTY COPY GOALS: Describe the basic clinical and morphologic features of various

More information

Melanoma 6/2/2011. Classification and Prognosis. Melanoma Statistics. American Cancer Society

Melanoma 6/2/2011. Classification and Prognosis. Melanoma Statistics. American Cancer Society University of Pennsylvania, Ben Franklin in front of Charles Addams Building Melanoma Classification and Prognosis Emphasizing Pathology & History David Elder University of Pennsylvania Melanoma Statistics

More information

Common Benign Lesions and Skin Cancers. 22nd May 2015 Dr Mark Foley

Common Benign Lesions and Skin Cancers. 22nd May 2015 Dr Mark Foley Common Benign Lesions and Skin Cancers 22nd May 2015 Dr Mark Foley Thank you for downloading this file. This intended to supplement the presentation given at the NZ Wound Care Conference, it is not intended

More information

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior

More information

Malignant Melanoma Early Stage. A guide for patients

Malignant Melanoma Early Stage. A guide for patients This melanoma patient brochure is designed to help educate melanoma patients and their caregivers. It was developed under the guidance of Dr. Michael Smylie, Professor, Department of Oncology, University

More information

Objectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells

Objectives. Atypical Glandular Cells. Atypical Endocervical Cells. Reactive Endocervical Cells 2013 California Society of Pathologists 66 th Annual Meeting San Francisco, CA Atypical Glandular Cells to Early Invasive Adenocarcinoma: Cervical Cytology and Histology Christina S. Kong, MD Associate

More information

Brief Report. Shivanand Gundalli 1, Smita Kadadavar 1, Somil Singhania 1, Rutuja Kolekar 2 INTRODUCTION. Melanocytic Nevus

Brief Report. Shivanand Gundalli 1, Smita Kadadavar 1, Somil Singhania 1, Rutuja Kolekar 2 INTRODUCTION. Melanocytic Nevus Our Dermatology Online Histopathological spectrum of benign melanocytic nevi our experience in a tertiary care centre Shivanand Gundalli 1, Smita Kadadavar 1, Somil Singhania 1, Rutuja Kolekar 2 1 Department

More information

Index. Springer-Verlag Berlin Heidelberg 2017 J.A. Plaza, V.G. Prieto, Pathology of Pigmented Skin Lesions, DOI /

Index. Springer-Verlag Berlin Heidelberg 2017 J.A. Plaza, V.G. Prieto, Pathology of Pigmented Skin Lesions, DOI / A Acral lentiginous (mucosal lentiginous) melanoma, 483 Acral lentiginous melanoma (ALM) asymmetric and irregular lentiginous junctional growth, 431 clinical features, 427 428 differential diagnosis, 428

More information

This is a repository copy of Easily missed? Amelanotic melanoma. White Rose Research Online URL for this paper:

This is a repository copy of Easily missed? Amelanotic melanoma. White Rose Research Online URL for this paper: This is a repository copy of Easily missed? Amelanotic melanoma. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/127789/ Version: Accepted Version Article: Muinonen-Martin,

More information

Regression 2/3/18. Histologically regression is characterized: melanosis fibrosis combination of both. Distribution: partial or focal!

Regression 2/3/18. Histologically regression is characterized: melanosis fibrosis combination of both. Distribution: partial or focal! Regression Margaret Oliviero MSN, ARNP Harold S. Rabinovitz MD Histologically regression is characterized: melanosis fibrosis combination of both Distribution: partial or focal! Dermatoscopic terminology

More information